News-Papers
Testimonial
Video Gallery
Melatonin and its contribution to tumor attenuation in systemic malignancies
Published on Thursday, 14 August 2014
Letter To The Editor
See also About Melatonin.
Search
Follow us...
Latest
- Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives
- Melatonin in cancer management: progress and promise
- Radioprotective effect of melatonin on the cervical spinal cord in irradiated rats
- Protective effects of melatonin and vitamin E in brain damage due to gamma radiation: an experimental study
- Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
- The impact of vitamin D on cancer: A mini review
- Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
- Radio-Protective Effects of Melatonin on Subventricular Zone in Irradiated Rat: Decrease in Apoptosis and Upregulation of Nestin
- Modulating effects of famotidine and melatonin on high dose radiation induced cell lethality in normal human and cancer cell lines
- Melatonin Sensitizes Human Colorectal Cancer Cells to γ-ray Ionizing Radiation In Vitro and In Vivo
- Melatonin: an endogenous miraculous indolamine, fights against cancer progression
- Melatonin: An Endogenous Antiestrogen with Oncostatic Properties
- Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
- Disease Control after Androgen Deprivation Therapy Combined with Di Bella Multitherapy
- Somatostatin and Somatostatin Receptors in Tumour Biology
- Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
- Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation
- Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer